Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Researchers develop a new murine model of seizures with Chd8 haploinsufficiency

Oct. 22, 2020

Phase IIb study in Japan of KW-6356 for Parkinson's disease meets primary endpoint

Oct. 21, 2020

Amicus presents interim phase I/II data for AT-GTX-501 gene therapy

Oct. 21, 2020

European researchers patent new compounds for epilepsy

Oct. 21, 2020

Aptinyx reports promising phase II data on NYX-783 in PTSD

Oct. 20, 2020

Yichang Humanwell Pharmaceutical synthesizes kappa-opioid receptor agonists

Oct. 20, 2020

Positive interim data presented from phase III SHORELINE study of zuranolone in MDD

Oct. 20, 2020

TRPA1 channel as a new therapeutic target for chronic post-thoracotomy pain

Oct. 19, 2020

Neutrophils are literal obstacle to stroke recovery

Oct. 19, 2020

University of Barcelona discovers soluble epoxide hydrolase and acetylcholinesterase inhibitors

Oct. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...